ANUH PHARMA LIMITED Share Price

₹ 81.45

+₹0.30 (0.37%)

Last updated 03 Nov, 2026, 15:53 IST

NSE: ANUHPHR

ANUH PHARMA LIMITED Share Price Today

As of 4 Nov 2026, ANUH PHARMA LIMITED share price is ₹81.45. The stock opened at ₹81.25, compared to its previous close of ₹81.15. During today's trading session, ANUH PHARMA LIMITED share price moved in the range of ₹81.45 to ₹81.45, with an average price of ₹81.45 for the day. Looking at its last 52-week, the stock has touched a low of ₹67.00 and a high of ₹99.50. On the performance front, ANUH PHARMA LIMITED share price has declined by 0.06% over the last six months and is down 9.08% on a year-on-year basis.

₹81.45

0.37% up today

₹81.45

1D LOW

1D HIGH

ANUH PHARMA LIMITED Stock Insights

Stock Performance

OutperformingBeat Nifty by 5.74 % in last 3 month

Shareholding Pattern

DIIDII increased stake by 50.00%

Shareholding Pattern

FIIFII increased stake by 867.24%

ANUH PHARMA LIMITED Stock Insights

Stock Performance

OutperformingBeat Nifty by 5.74 % in last 3 month

Shareholding Pattern

DIIDII increased stake by 50.00%

Shareholding Pattern

FIIFII increased stake by 867.24%

ANUH PHARMA LIMITED stock performance
Open	₹81.25
High	₹81.45
Low	₹81.45
Prev. close	₹81.15

ANUH PHARMA LIMITED trading activity
Volume	158
Average traded price	--
Last traded time	03:53:33 03 Nov
Last traded quantity	10

₹64.92₹97.38

Circuit Low

Circuit High

₹67.00₹99.50

52-Week Low

52-Week High

Circuit

₹64.92

₹97.38

52-week

₹67.00

₹99.50

Mkt Cap Cr

847.19

P/E

16.95

P/B

2.25

ROA

8.63%

ROE

13.27%

ROCE

17.28%

Quick Ratio

1.5

EV/EBITDA

11.21

Mkt Cap Cr

847.19

P/E

16.95

P/B

2.25

ROA

8.63%

ROE

13.27%

ROCE

17.28%

Quick Ratio

1.5

EV/EBITDA

11.21

Based on fundamentals, this stock's

Performance

Neutral

Anuh Pharma performance is moderate compared to markets

Valuation

Overvalued

Anuh Pharma appears overvalued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROA	ROE	ROCE	Quick Ratio	EV/EBITDA
Sun Pharmaceutical Industries	4,24,202.42	38.61	4.75	9.61%	13.79%	18.65%	2.31	22.27
Divis Laboratories	2,64,141.24	90.31	15.76	14.6%	15.32%	19.56%	3.5	58.97
Torrent Pharmaceuticals	1,74,402.47	84.0	9.6	4.7%	11.42%	11.37%	0.75	33.48
Laurus Labs	1,26,811.28	94.08	20.68	11.58%	22.11%	20.91%	0.68	53.48
Zydus Lifesciences	1,23,685.49	26.93	4.56	8.57%	18.59%	17.35%	0.91	16.42
Dr. Reddy's Laboratories	1,11,868.03	40.54	2.88	4.79%	7.21%	8.58%	1.35	19.05
Cipla	1,11,647.72	39.12	3.15	6.6%	8.18%	10.8%	2.5	21.03
Mankind Pharma	1,02,315.40	45.2	5.82	7.82%	12.76%	14.68%	0.74	24.9
Aurobindo Pharma	96,951.18	26.13	2.56	6.34%	9.25%	11.76%	1.15	12.38
Lupin	91,300.83	16.57	4.1	14.47%	23.76%	24.88%	1.42	9.76

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

ANUH PHARMA LIMITED Company Background

ISIN

INE489G01022

Sector Market Cap

₹ 847.19 Cr

Anuh Pharma Limited is engaged in the business of manufacturing and selling bulk drugs and chemicals. The Company's products include active pharmaceutical ingredients and corticosteroids. Its active pharmaceutical ingredients include macrolides, anti-TB, anti-malarial, antibacterial, anti-hypertension, expectorant, quinolones, intermediates and under development. Its macrolides products include erythromycin, erythromycin ethyl succinate, erythromycin stearate, erythromycin estolate, erythromycin propionate, erythromycin phosphate, and others. Its anti-malarial products include sulfadoxine, pyrimethamine, and others. The Company's anti-hypertension products include losartan potassium, telmisartan and atorvastatin calcium. The Company's corticosteroids include anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic, antihistamines and under development. Its anti-inflammatory products include dexamethasone Na phosphate, mometasone furoate and clobetasol butyrate.

ANUH PHARMA LIMITED Financial Highlights

Revenue: ANUH PHARMA LIMITED reported revenue of ₹776.02 crore in FY26 vs ₹670.97 crore in FY25. It showed an increase of 15.66% on a yearly basis.
Operating Profit: ANUH PHARMA LIMITED reported an operating profit of ₹54.22 crore in FY26 vs ₹61.01 crore in FY25. It showed a decrease of 11.13% on a year-on-year basis.
Net Profit: ANUH PHARMA LIMITED reported a net profit of ₹41.05 crore in FY26 vs ₹47.35 crore in FY25. It showed a decrease of 13.31% on a yearly basis.

ANUH PHARMA LIMITED Quarterly Result Highlights

ANUH PHARMA LIMITED reported revenue of ₹185.85 crore in Sep 2026, compared with ₹196.89 crore in Jun 2026, representing a decrease of 5.61% on a quarter-on-quarter (QoQ) basis.
ANUH PHARMA LIMITED reported an operating profit of ₹15.05 crore in Sep 2026, compared with ₹16.93 crore in Jun 2026, representing a decrease of 11.10% on a quarter-on-quarter (QoQ) basis.
ANUH PHARMA LIMITED reported a profit of ₹11.21 crore in Sep 2026, compared with ₹11.42 crore in Jun 2026, reflecting a decrease of 1.84% on a QoQ basis.
The earnings per share (EPS) of ANUH PHARMA LIMITED stood at ₹4.10 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters

71.80%

FII

0.11%

Other DII

0.00%

Retail and other

28.09%

Mutual funds

0.00%

Foreign Institutional Investor (FII)

FII shareholding by period
Dec 2025	0.00%
Mar 2026	0.05%
Jun 2026	0.01%
Sep 2026	0.11%

ANUH PHARMA LIMITED Investment Returns

1 day

-4.03%

1 week

+2.53%

1 month

-5.47%

1 year

-9.08%

3 years

-27.17%

5 years

-27.17%

ANUH PHARMA LIMITED Share Price History

ANUH PHARMA LIMITED share price history by day, showing open and close prices and the percentage change
Day	Open / Close	Change %
03 Nov 26	₹84.56 / ₹81.15	-4.03%
02 Nov 26	₹87.60 / ₹84.56	-3.15%
30 Oct 26	₹80.50 / ₹87.31	+9.49%
29 Oct 26	₹81.50 / ₹79.74	+0.16%
28 Oct 26	₹79.90 / ₹79.61	+0.58%
27 Oct 26	₹77.95 / ₹79.15	+2.71%
26 Oct 26	₹76.35 / ₹77.06	+0.56%
23 Oct 26	₹80.38 / ₹76.63	-2.84%
22 Oct 26	₹80.60 / ₹78.87	-1.25%
21 Oct 26	₹84.45 / ₹79.87	-3.53%

ANUH PHARMA LIMITED Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Revenue	₹771.66	₹661.51	₹647.00	₹527.49
Other Income	₹4.36	₹9.46	₹12.10	₹6.11
Total Revenue	₹776.01	₹670.97	₹659.10	₹533.60
Total Expenses	₹721.79	₹609.96	₹580.79	₹486.13
Profit Before Tax	₹54.22	₹61.01	₹78.31	₹47.47
Tax	₹13.18	₹13.65	₹18.25	₹11.29
Profit After Tax	₹41.05	₹47.35	₹60.06	₹36.18
EPS - Basic	₹4.10	₹9.45	₹11.98	₹7.22
EPS - Diluted	₹4.10	₹9.45	₹11.98	₹7.22

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Profit before tax	₹54.22	₹61.01	₹78.31	₹47.47
Income before WC changes	₹65.14	₹61.33	₹75.58	₹51.00
Change in Assets	-₹82.21	-₹30.84	-₹32.34	-₹17.85
Change in Liabilities	₹27.30	₹17.76	-₹11.24	₹34.21
Change in WC	-₹54.91	-₹13.09	-₹43.58	₹16.37
Cash flow from Operations	-₹3.01	₹37.12	₹12.93	₹53.90
Cash flow from Investing	₹17.84	-₹19.91	₹0.92	-₹43.48
Cash flow from Financing	-₹26.33	-₹4.86	-₹8.57	-₹12.29
Total Cash Flow	-₹11.50	₹12.36	₹5.27	-₹1.87
Cash (Start of the year)	₹19.56	₹7.20	₹1.93	₹3.80
Cash (End of the year)	₹8.06	₹19.56	₹7.20	₹1.93

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2026	Mar 2025	Mar 2024	Mar 2023
Non-Current Assets	₹106.05	₹130.46	₹107.14	₹97.37
Current Assets	₹451.32	₹376.17	₹338.54	₹307.61
Total Assets	₹557.37	₹506.63	₹445.68	₹404.98
Current Liabilities	₹203.00	₹178.51	₹152.69	₹161.34
Net Current Asset	₹248.31	₹197.66	₹185.84	₹146.28
Non-Current Liabilities	₹2.14	₹2.09	₹1.77	₹2.42
Equity Capital	₹352.22	₹326.02	₹291.22	₹241.22
Total Equity & Liabilities	₹557.37	₹506.63	₹445.68	₹404.98